06-25-2009, 06:58 PM
|
#22 |
| Donating YT 1000 Club Member
Join Date: Mar 2009 Location: Houston, Texas USA
Posts: 2,473
|  Quote:
Originally Posted by lil fu fu girl According to the Dec 3, 2007 AVMA Journal, two main issues complicate the decision of mircochipping our pets. The first pertains to the currently unregulated industry of microchip frequencies here in the US. Two of the top 5 US producers of RFID microchips are currently producing them at a frequency of 125 kHz and 128 kHz. To complicate matters, these RFID microchips produced by these companies can only be read by their scanners manufactured by their company. Another company’s scanner might detect the chip, but not be able to recover any information. The AVMA is quoted as stating, “Nine state veterinary medical associations submitted Resolution 4, which states "a lack of standardization in RFID (microchips) for companion animals in the United States has decreased the ability of the public to regain a lost pet in spite of microchip identification.”(JAVMA/05) The second issue deals with the adverse medical complications that are possible. Infections, migration, swelling, and yes, cancer is possible. Some have stated that the mice used for these experiments are “genetically engineered to produce tumors”. This rumor was actually perpetuated by the Verichip Corporation and pertains to the 1999 Blanchard study, in which the p53+/- mouse was genetically modified to have an increased susceptibility to cancer only when exposed to genotoxins or substances that damage genetic material. These mice are not known to develop spontaneous tumors in the absence of genotoxins within the first six months of life, which is when the microchip-induced tumors in this particular study arose. This study, along with several others: the 1998 Ridgefield Connecticut study, the 2006 E. Elcock study, the M. Vascellari study, and others that negatively depicted microchips, were not reviewed in the 2005 FDA approval ruling. FYI: the FDA is overseen by the Department of Health and Human Services, which, at the time of VeriChip’s approval, was headed by Tommy Thompson. Two weeks after the device’s FDA approval took effect on January 10, 2005, Thompson left his Cabinet post, and within five months was a board member of VeriChip Corp. He was also compensated by the company with $40,000 in cash, 166,667 shares of VeriChip Corp. stock, and options on 100,000 shares of VeriChips parent company, Applied Digital Solutions; according to the SEC! Currently, IBM holds a major stake in VeriChip Corp, and is petitioning the government with RFID technology for the tracking of humans. The two Corporations have a joint Austin, Texas laboratory used specifically for the testing of human RFID's. When asked about RFID testing on humans, VeriChip stated that the RFID technology would definitely have to be tested out on larger animals such as dogs and cats before human trials could begin. | |
| |